Cargando…
Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019
We examined the epidemiological trends, including the distribution of sex, age, and disease etiology, in HCC incident cases, over 24 years. Data of 20,547 HCC patients (1996–2019) were analyzed in this prospective study. We divided the study period into four 6-yearly quarters. HCC etiology was categ...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795252/ https://www.ncbi.nlm.nih.gov/pubmed/35087153 http://dx.doi.org/10.1038/s41598-022-05444-z |
_version_ | 1784641021302276096 |
---|---|
author | Nakano, Masahito Yatsuhashi, Hiroshi Bekki, Shigemune Takami, Yuko Tanaka, Yasuhito Yoshimaru, Yoko Honda, Koichi Komorizono, Yasuji Harada, Masaru Shibata, Michihiko Sakisaka, Shotaro Shakado, Satoshi Nagata, Kenji Yoshizumi, Tomoharu Itoh, Shinji Sohda, Tetsuro Oeda, Satoshi Nakao, Kazuhiko Sasaki, Ryu Yamashita, Tsutomu Ido, Akio Mawatari, Seiichi Nakamuta, Makoto Aratake, Yoshifusa Matsumoto, Shuichi Maeshiro, Tatsuji Goto, Takashi Torimura, Takuji |
author_facet | Nakano, Masahito Yatsuhashi, Hiroshi Bekki, Shigemune Takami, Yuko Tanaka, Yasuhito Yoshimaru, Yoko Honda, Koichi Komorizono, Yasuji Harada, Masaru Shibata, Michihiko Sakisaka, Shotaro Shakado, Satoshi Nagata, Kenji Yoshizumi, Tomoharu Itoh, Shinji Sohda, Tetsuro Oeda, Satoshi Nakao, Kazuhiko Sasaki, Ryu Yamashita, Tsutomu Ido, Akio Mawatari, Seiichi Nakamuta, Makoto Aratake, Yoshifusa Matsumoto, Shuichi Maeshiro, Tatsuji Goto, Takashi Torimura, Takuji |
author_sort | Nakano, Masahito |
collection | PubMed |
description | We examined the epidemiological trends, including the distribution of sex, age, and disease etiology, in HCC incident cases, over 24 years. Data of 20,547 HCC patients (1996–2019) were analyzed in this prospective study. We divided the study period into four 6-yearly quarters. HCC etiology was categorized as hepatitis B virus (HBV) infection, HBV + hepatitis C virus (HCV) infection, HCV infection, and both negative (non-BC). The incident cases of HCC per quarter of the study period were 4311 (21.0%), 5505 (26.8%), 5776 (28.1%), and 4955 (24.1%), sequentially. Overall, 14,020 (68.2%) patients were male. The number of HCC cases in patients < 60 years, 60–69 years, 70–79 years, and ≥ 80 years were 3711 (18.1%), 6652 (32.4%), 7448 (36.2%), and 2736 (13.3%), respectively. The average age of newly-diagnosed patients increased in each quarter. HCC was associated with HBV, HBV + HCV, and HCV infections and non-BC in 2997 (14.6%), 187 (0.9%), and 12,019 (58.5%), and 5344 (26.0%) cases, respectively. The number of HCV-associated cases decreased in each quarter, while that of non-BC-associated cases increased. HCC incident cases tend to increase in the elderly and in non-BC patients; in contrast, HCC incident cases due to HCV tend to decrease. |
format | Online Article Text |
id | pubmed-8795252 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-87952522022-01-28 Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019 Nakano, Masahito Yatsuhashi, Hiroshi Bekki, Shigemune Takami, Yuko Tanaka, Yasuhito Yoshimaru, Yoko Honda, Koichi Komorizono, Yasuji Harada, Masaru Shibata, Michihiko Sakisaka, Shotaro Shakado, Satoshi Nagata, Kenji Yoshizumi, Tomoharu Itoh, Shinji Sohda, Tetsuro Oeda, Satoshi Nakao, Kazuhiko Sasaki, Ryu Yamashita, Tsutomu Ido, Akio Mawatari, Seiichi Nakamuta, Makoto Aratake, Yoshifusa Matsumoto, Shuichi Maeshiro, Tatsuji Goto, Takashi Torimura, Takuji Sci Rep Article We examined the epidemiological trends, including the distribution of sex, age, and disease etiology, in HCC incident cases, over 24 years. Data of 20,547 HCC patients (1996–2019) were analyzed in this prospective study. We divided the study period into four 6-yearly quarters. HCC etiology was categorized as hepatitis B virus (HBV) infection, HBV + hepatitis C virus (HCV) infection, HCV infection, and both negative (non-BC). The incident cases of HCC per quarter of the study period were 4311 (21.0%), 5505 (26.8%), 5776 (28.1%), and 4955 (24.1%), sequentially. Overall, 14,020 (68.2%) patients were male. The number of HCC cases in patients < 60 years, 60–69 years, 70–79 years, and ≥ 80 years were 3711 (18.1%), 6652 (32.4%), 7448 (36.2%), and 2736 (13.3%), respectively. The average age of newly-diagnosed patients increased in each quarter. HCC was associated with HBV, HBV + HCV, and HCV infections and non-BC in 2997 (14.6%), 187 (0.9%), and 12,019 (58.5%), and 5344 (26.0%) cases, respectively. The number of HCV-associated cases decreased in each quarter, while that of non-BC-associated cases increased. HCC incident cases tend to increase in the elderly and in non-BC patients; in contrast, HCC incident cases due to HCV tend to decrease. Nature Publishing Group UK 2022-01-27 /pmc/articles/PMC8795252/ /pubmed/35087153 http://dx.doi.org/10.1038/s41598-022-05444-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Nakano, Masahito Yatsuhashi, Hiroshi Bekki, Shigemune Takami, Yuko Tanaka, Yasuhito Yoshimaru, Yoko Honda, Koichi Komorizono, Yasuji Harada, Masaru Shibata, Michihiko Sakisaka, Shotaro Shakado, Satoshi Nagata, Kenji Yoshizumi, Tomoharu Itoh, Shinji Sohda, Tetsuro Oeda, Satoshi Nakao, Kazuhiko Sasaki, Ryu Yamashita, Tsutomu Ido, Akio Mawatari, Seiichi Nakamuta, Makoto Aratake, Yoshifusa Matsumoto, Shuichi Maeshiro, Tatsuji Goto, Takashi Torimura, Takuji Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019 |
title | Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019 |
title_full | Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019 |
title_fullStr | Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019 |
title_full_unstemmed | Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019 |
title_short | Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019 |
title_sort | trends in hepatocellular carcinoma incident cases in japan between 1996 and 2019 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795252/ https://www.ncbi.nlm.nih.gov/pubmed/35087153 http://dx.doi.org/10.1038/s41598-022-05444-z |
work_keys_str_mv | AT nakanomasahito trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT yatsuhashihiroshi trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT bekkishigemune trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT takamiyuko trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT tanakayasuhito trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT yoshimaruyoko trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT hondakoichi trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT komorizonoyasuji trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT haradamasaru trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT shibatamichihiko trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT sakisakashotaro trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT shakadosatoshi trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT nagatakenji trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT yoshizumitomoharu trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT itohshinji trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT sohdatetsuro trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT oedasatoshi trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT nakaokazuhiko trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT sasakiryu trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT yamashitatsutomu trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT idoakio trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT mawatariseiichi trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT nakamutamakoto trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT aratakeyoshifusa trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT matsumotoshuichi trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT maeshirotatsuji trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT gototakashi trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 AT torimuratakuji trendsinhepatocellularcarcinomaincidentcasesinjapanbetween1996and2019 |